Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells

Brooke A. DeRosa, Jessica M. Van Baaren, Gaurav K. Dubey, Joycelyn M. Lee, Michael Cuccaro, Jeffery M Vance, Margaret A Pericak-Vance, Derek M Dykxhoorn

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Induced pluripotent stem cells (iPSCs) hold tremendous potential both as a biological tool to uncover the pathophysiology of disease by creating relevant cell models and as a source of stem cells for cell-based therapeutic applications. Typically, iPSCs have been derived by the transgenic overexpression of transcription factors associated with progenitor cell or stem cell function in fibroblasts derived from skin biopsies. However, the need for skin punch biopsies to derive fibroblasts for reprogramming can present a barrier to study participation among certain populations of individuals, including children with autism spectrum disorders (ASDs). In addition, the acquisition of skin punch biopsies in non-clinic settings presents a challenge. One potential mechanism to avoid these limitations would be the use of peripheral blood mononuclear cells (PBMCs) as the source of the cells for reprogramming. In this article we describe, for the first time, the derivation of iPSC lines from PBMCs isolated from the whole blood of autistic children, and their subsequent differentiation in GABAergic neurons.

Original languageEnglish
Pages (from-to)9-14
Number of pages6
JournalNeuroscience Letters
Volume516
Issue number1
DOIs
StatePublished - May 10 2012

Fingerprint

Induced Pluripotent Stem Cells
Blood Cells
Stem Cells
Biopsy
Skin
Fibroblasts
GABAergic Neurons
Transcription Factors
Cell Line
Population
Autism Spectrum Disorder
Therapeutics

Keywords

  • Autism spectrum disorder (ASD)
  • Differentiation
  • Induced pluripotent stem cells (iPSC)
  • Reprogramming

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells. / DeRosa, Brooke A.; Van Baaren, Jessica M.; Dubey, Gaurav K.; Lee, Joycelyn M.; Cuccaro, Michael; Vance, Jeffery M; Pericak-Vance, Margaret A; Dykxhoorn, Derek M.

In: Neuroscience Letters, Vol. 516, No. 1, 10.05.2012, p. 9-14.

Research output: Contribution to journalArticle

@article{7cf78179f90047ae8b9d780b8cb8ad12,
title = "Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells",
abstract = "Induced pluripotent stem cells (iPSCs) hold tremendous potential both as a biological tool to uncover the pathophysiology of disease by creating relevant cell models and as a source of stem cells for cell-based therapeutic applications. Typically, iPSCs have been derived by the transgenic overexpression of transcription factors associated with progenitor cell or stem cell function in fibroblasts derived from skin biopsies. However, the need for skin punch biopsies to derive fibroblasts for reprogramming can present a barrier to study participation among certain populations of individuals, including children with autism spectrum disorders (ASDs). In addition, the acquisition of skin punch biopsies in non-clinic settings presents a challenge. One potential mechanism to avoid these limitations would be the use of peripheral blood mononuclear cells (PBMCs) as the source of the cells for reprogramming. In this article we describe, for the first time, the derivation of iPSC lines from PBMCs isolated from the whole blood of autistic children, and their subsequent differentiation in GABAergic neurons.",
keywords = "Autism spectrum disorder (ASD), Differentiation, Induced pluripotent stem cells (iPSC), Reprogramming",
author = "DeRosa, {Brooke A.} and {Van Baaren}, {Jessica M.} and Dubey, {Gaurav K.} and Lee, {Joycelyn M.} and Michael Cuccaro and Vance, {Jeffery M} and Pericak-Vance, {Margaret A} and Dykxhoorn, {Derek M}",
year = "2012",
month = "5",
day = "10",
doi = "10.1016/j.neulet.2012.02.086",
language = "English",
volume = "516",
pages = "9--14",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells

AU - DeRosa, Brooke A.

AU - Van Baaren, Jessica M.

AU - Dubey, Gaurav K.

AU - Lee, Joycelyn M.

AU - Cuccaro, Michael

AU - Vance, Jeffery M

AU - Pericak-Vance, Margaret A

AU - Dykxhoorn, Derek M

PY - 2012/5/10

Y1 - 2012/5/10

N2 - Induced pluripotent stem cells (iPSCs) hold tremendous potential both as a biological tool to uncover the pathophysiology of disease by creating relevant cell models and as a source of stem cells for cell-based therapeutic applications. Typically, iPSCs have been derived by the transgenic overexpression of transcription factors associated with progenitor cell or stem cell function in fibroblasts derived from skin biopsies. However, the need for skin punch biopsies to derive fibroblasts for reprogramming can present a barrier to study participation among certain populations of individuals, including children with autism spectrum disorders (ASDs). In addition, the acquisition of skin punch biopsies in non-clinic settings presents a challenge. One potential mechanism to avoid these limitations would be the use of peripheral blood mononuclear cells (PBMCs) as the source of the cells for reprogramming. In this article we describe, for the first time, the derivation of iPSC lines from PBMCs isolated from the whole blood of autistic children, and their subsequent differentiation in GABAergic neurons.

AB - Induced pluripotent stem cells (iPSCs) hold tremendous potential both as a biological tool to uncover the pathophysiology of disease by creating relevant cell models and as a source of stem cells for cell-based therapeutic applications. Typically, iPSCs have been derived by the transgenic overexpression of transcription factors associated with progenitor cell or stem cell function in fibroblasts derived from skin biopsies. However, the need for skin punch biopsies to derive fibroblasts for reprogramming can present a barrier to study participation among certain populations of individuals, including children with autism spectrum disorders (ASDs). In addition, the acquisition of skin punch biopsies in non-clinic settings presents a challenge. One potential mechanism to avoid these limitations would be the use of peripheral blood mononuclear cells (PBMCs) as the source of the cells for reprogramming. In this article we describe, for the first time, the derivation of iPSC lines from PBMCs isolated from the whole blood of autistic children, and their subsequent differentiation in GABAergic neurons.

KW - Autism spectrum disorder (ASD)

KW - Differentiation

KW - Induced pluripotent stem cells (iPSC)

KW - Reprogramming

UR - http://www.scopus.com/inward/record.url?scp=84860232921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860232921&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2012.02.086

DO - 10.1016/j.neulet.2012.02.086

M3 - Article

VL - 516

SP - 9

EP - 14

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -